Papers

Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes

Diabetes and Arthritis Epidemiology Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases and National Insitute of Arthritis and Musculoskeletal and Skin Diseases, Phoenix, Arizona 85014, United States Correspondence to: Dr D R McCance, Sir George E Clark Metabolic Unit, Royal Victoria Hospital Belfast BT12 6BA.

Abstract

Objective : To compare the ability of tests measuring two hour plasma glucose, fasting plasma glucose, and glycated haemoglobin concentrations in predicting the specific microvascular complications of non-insulin dependent diabetes mellitus.
Design : Cross sectional and longitudinal analysis of the relation between complications and concomitant results of the three tests.
Setting : Gila River Indian Community, Arizona.
Subjects : Pima Indians (cross sectional, n=960),aged 25 years or above who were not receiving insulin or oral hypoglycaemic treatment at the baseline examination.
Main outcome measures : Development of retinopathy and nephropathy.
Results : Cross sectionally, frequency distributions of logarithms of the three sets of results were bimodal, with the prevalence of retinopathy and nephropathy being, respectively, 12.0-26.7 and 3.9-4.2 times as high above as below cut off points which minimised overlap (two hour plasma glucose concentration 12.6 mmol/l; fasting plasma glucose concentration 9.3mmol/l; glycated haemoglobin (HbA1c) concentration 7.8%). Longitudinally, each of the three measures of glycaemia significantly predicted the development of retinopathy (P<0.0001) and nephropathy (P<0.05). Receiver operating characteristic curves showed that two hour plasma glucose concentration was superior to fasting plasma glucose concentration (P<0.05) for prevalent cases of retinopathy, but otherwise no variable had a significant advantage for detecting incident or prevalent cases of either complication.
Conclusions : These findings suggest that determination of glycated haemoglobin or fasting plasma glucose concentrations alone may be acceptable alternatives to measuring glucose concentration two hours after challenge with 75 g glucose for the diagnosis of diabetes.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Article

Tests for diagnosing diabetes mellitus Glucose tolerance test is most sensitive

K Simon, A Sinclair, D McHugh, M Roubicek, A Gonzalez Sanguineti, G Vines, G Jermendy, D R McCance, R L Hanson, M A Charles, L T H Jacobsson, D J Pettitt, P H Bennett, and W C Knowler
BMJ 1994 309: 537-538. [Extract] [Full Text]

This article has been cited by other articles:

• Cheng, Y. J., Gregg, E. W., Geiss, L. S., Imperatore, G., Williams, D. E., Zhang, X., Albright, A. L., Cowie, C. C., Klein, R., Saaddine, J. B. (2009). Association of A1C and Fasting Plasma Glucose Levels With Diabetic Retinopathy Prevalence in the U.S. Population: Implications for diabetes diagnostic thresholds. Diabetes Care 32: 2027-2032 [Abstract] [Full text]  
• Cox, M. E., Edelman, D. (2009). Tests for Screening and Diagnosis of Type 2 Diabetes. Clin. Diabetes 27: 132-138 [Abstract] [Full text]  
• Nang, E. E. K., Khoo, C. M., Tai, E. S., Lim, S. C., Tavintharan, S., Wong, T. Y., Heng, D., Lee, J. (2009). Is There a Clear Threshold for Fasting Plasma Glucose That Differentiates Between Those With and Without Neuropathy and Chronic Kidney Disease?: The Singapore Prospective Study Program. Am J Epidemiol 169: 1454-1462 [Abstract] [Full text]  
• Bloomgarden, Z. T. (2009). Topics in Type 2 Diabetes and Insulin Resistance. Diabetes Care 32: e13-e19 [Full text]  
• Likhari, T., Aulakh, T S, Singh, B. M, Gama, R (2008). Does HbA1C predict isolated impaired fasting glycaemia in the oral glucose tolerance test in subjects with impaired fasting glycaemia?. Ann Clin Biochem 45: 418-420 [Abstract] [Full text]  
• Saudek, C. D., Herman, W. H., Sacks, D. B., Bergenstal, R. M., Edelman, D., Davidson, M. B. (2008). A New Look at Screening and Diagnosing Diabetes Mellitus. J. Clin. Endocrinol. Metab. 93: 2447-2453 [Abstract] [Full text]  
• U.S. Preventive Services Task Force, (2008). Screening for Type 2 Diabetes Mellitus in Adults: U.S. Preventive Services Task Force Recommendation Statement. ANN INTERN MED 148: 846-854 [Abstract] [Full text]  
• Rahman, M., Simmons, R. K, Harding, A.-H., Wareham, N. J, Griffin, S. J (2008). A simple risk score identifies individuals at high risk of developing Type 2 diabetes: a prospective cohort study. Fam Pract 25: 191-196 [Abstract] [Full text]  
• Thomas, C., Hypponen, E., Power, C. (2008). Obesity and Type 2 Diabetes Risk in Midadult Life: The Role of Childhood Adversity. Pediatrics 121: e1240-e1249 [Abstract] [Full text]  
• Bloom, R. D., Crutchlow, M. F. (2008). New-Onset Diabetes Mellitus in the Kidney Recipient: Diagnosis and Management Strategies. CJASN 3: S38-S48 [Abstract] [Full text]  
• Bloomgarden, Z. T. (2007). Screening for and managing diabetic retinopathy: Current approaches. Am J Health Syst Pharm 64: S8-S14 [Abstract] [Full text]  
• Crutchlow, M. F., Bloom, R. D. (2007). Transplant-Associated Hyperglycemia: A New Look at an Old Problem. CJASN 2: 343-355 [Abstract] [Full text]  
• Myint, P. K., Sinha, S., Wareham, N. J., Bingham, S. A., Luben, R. N., Welch, A. A., Khaw, K.-T. (2007). Glycated Hemoglobin and Risk of Stroke in People Without Known Diabetes in the European Prospective Investigation Into Cancer (EPIC)-Norfolk Prospective Population Study: A Threshold Relationship?. Stroke 38: 271-275 [Abstract] [Full text]  
• Droumaguet, C., Balkau, B., Simon, D., Caces, E., Tichet, J., Charles, M. A., Eschwege, E., the DESIR Study Group, (2006). Use of HbA1c in Predicting Progression to Diabetes in French Men and Women: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 29: 1619-1625 [Abstract] [Full text]  
• Thomas, C., Hypponen, E., Power, C. (2006). Type 2 diabetes mellitus in midlife estimated from the cambridge risk score and body mass index.. Arch Intern Med 166: 682-688 [Abstract] [Full text]  
• Heine, R. J., Van Gaal, L. F., Johns, D., Mihm, M. J., Widel, M. H., Brodows, R. G., for the GWAA Study Group*, (2005). Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes: A Randomized Trial. ANN INTERN MED 143: 559-569 [Abstract] [Full text]  
• Petersen, J. L, McGuire, D. K (2005). Impaired glucose tolerance and impaired fasting glucose -- a review of diagnosis, clinical implications and management. Diabetes and Vascular Disease Research 2: 9-15 [Abstract]  
• Khaw, K.-T., Wareham, N., Bingham, S., Luben, R., Welch, A., Day, N. (2004). Association of Hemoglobin A1c with Cardiovascular Disease and Mortality in Adults: The European Prospective Investigation into Cancer in Norfolk. ANN INTERN MED 141: 413-420 [Abstract] [Full text]  
• Jorgensen, L., Jenssen, T., Joakimsen, O., Heuch, I., Ingebretsen, O. C., Jacobsen, B. K. (2004). Glycated Hemoglobin Level Is Strongly Related to the Prevalence of Carotid Artery Plaques With High Echogenicity in Nondiabetic Individuals: The Tromso Study. Circulation 110: 466-470 [Abstract] [Full text]  
• Spijkerman, A. M.W., Yuyun, M. F., Griffin, S. J., Dekker, J. M., Nijpels, G., Wareham, N. J. (2004). The Performance of a Risk Score as a Screening Test for Undiagnosed Hyperglycemia in Ethnic Minority Groups: Data from the 1999 Health Survey for England. Diabetes Care 27: 116-122 [Abstract] [Full text]  
• Skrumsager, B. K., Nielsen, K. K., Muller, M., Pabst, G., Drake, P. G., Edsberg, B. (2003). Ragaglitazar: The Pharmacokinetics, Pharmacodynamics, and Tolerability of a Novel Dual PPAR{alpha} and {gamma} Agonist in Healthy Subjects and Patients with Type 2 Diabetes. J Clin Pharmacol 43: 1244-1256 [Abstract] [Full text]  
• SHIP, J. A. (2003). Diabetes and oral health: An overview. Journal of the American Dental Association 134: 4S-10S [Abstract] [Full text]  
• Spijkerman, A. M.W., Dekker, J. M., Nijpels, G., Adriaanse, M. C., Kostense, P. J., Ruwaard, D., Stehouwer, C. D.A., Bouter, L. M., Heine, R. J. (2003). Microvascular Complications at Time of Diagnosis of Type 2 Diabetes Are Similar Among Diabetic Patients Detected by Targeted Screening and Patients Newly Diagnosed in General Practice: The Hoorn Screening Study. Diabetes Care 26: 2604-2608 [Abstract] [Full text]  
• Greci, L. S., Kailasam, M., Malkani, S., Katz, D. L., Hulinsky, I., Ahmadi, R., Nawaz, H. (2003). Utility of HbA1c Levels for Diabetes Case Finding in Hospitalized Patients With Hyperglycemia. Diabetes Care 26: 1064-1068 [Abstract] [Full text]  
• Jesudason, D. R., Dunstan, K., Leong, D., Wittert, G. A. (2003). Macrovascular Risk and Diagnostic Criteria for Type 2 Diabetes: Implications for the use of FPG and HbA1c for cost-effective screening. Diabetes Care 26: 485-490 [Abstract] [Full text]  
• Scavini, M., Stidley, C. A., Shah, V. O., Narva, A. S., Tentori, F., Kessler, D. S., Bobelu, A., Albert, C. P., Bobelu, J., Jamon, E., Natachu, K., Neha, D., Waikaniwa, M., Welty, T. K., MacCluer, J. W., Zager, P. G. (2003). Prevalence of Diabetes Is Higher Among Female than Male Zuni Indians. Diabetes Care 26: 55-60 [Abstract] [Full text]  
• (2003). Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 26: s5-20 [Full text]  
• Charkoudian, N., Vella, A., Reed, A. S., Minson, C. T., Shah, P., Rizza, R. A., Joyner, M. J. (2002). Cutaneous vascular function during acute hyperglycemia in healthy young adults. J. Appl. Physiol. 93: 1243-1250 [Abstract] [Full text]  
• Barr, R G., Nathan, D. M., Meigs, J. B., Singer, D. E. (2002). Tests of Glycemia for the Diagnosis of Type 2 Diabetes Mellitus. ANN INTERN MED 137: 263-272 [Abstract] [Full text]  
• Wang, W., Lee, E. T., Fabsitz, R., Welty, T. K., Howard, B. V. (2002). Using HbA1c to Improve Efficacy of the American Diabetes Association Fasting Plasma Glucose Criterion in Screening for New Type 2 Diabetes in American Indians: The Strong Heart Study. Diabetes Care 25: 1365-1370 [Abstract] [Full text]  
• Park, P.J., Griffin, S.J., Sargeant, L., Wareham, N. J. (2002). The Performance of a Risk Score in Predicting Undiagnosed Hyperglycemia. Diabetes Care 25: 984-988 [Abstract] [Full text]  
• Sacks, D. B., Bruns, D. E., Goldstein, D. E., Maclaren, N. K., McDonald, J. M., Parrott, M. (2002). Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. Clin. Chem. 48: 436-472 [Abstract] [Full text]  
• Bando, Y., Ushiogi, Y., Okafuji, K., Toya, D., Tanaka, N., Fujisawa, M. (2001). The Relationship of Fasting Plasma Glucose Values and Other Variables to 2-h Postload Plasma Glucose in Japanese Subjects. Diabetes Care 24: 1156-1160 [Abstract] [Full text]  
• West, S. K., Klein, R., Rodriguez, J., Munoz, B., Broman, A. T., Sanchez, R., Snyder, R. (2001). Diabetes and Diabetic Retinopathy in a Mexican-American Population: Proyecto VER. Diabetes Care 24: 1204-1209 [Abstract] [Full text]  
• Krakoff, J., Hanson, R. L., Kobes, S., Knowler, W. C. (2001). Comparison of the Effect of Plasma Glucose Concentrations on Microvascular Disease Between Pima Indian Youths and Adults. Diabetes Care 24: 1023-1028 [Abstract] [Full text]  
• Wareham, N. J, Griffin, S. J (2001). Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria. BMJ 322: 986-988 [Full text]  
• Davidson, M. B. (2001). How Do We Diagnose Diabetes and Measure Blood Glucose Control?: View 1: (Diagnosing) A Clinical Basis for the Diagnosis of Diabetes. Diabetes Spectr. 14: 67-71 [Abstract] [Full text]  
• Perry, R. C., Shankar, R. R., Fineberg, N., McGill, J., Baron, A. D. (2001). HbA1c Measurement Improves the Detection of Type 2 Diabetes in High-Risk Individuals With Nondiagnostic Levels of Fasting Plasma Glucose: The Early Diabetes Intervention Program (EDIP). Diabetes Care 24: 465-471 [Abstract] [Full text]  
• Greenbaum, C. J., Cuthbertson, D., Krischer, J. P. (2001). Type 1 Diabetes Manifested Solely by 2-h Oral Glucose Tolerance Test Criteria. Diabetes 50: 470-476 [Abstract] [Full text]  
• Khaw, K.-T., Wareham, N., Luben, R., Bingham, S., Oakes, S., Welch, A., Day, N. (2001). Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ 322: 15-15 [Abstract] [Full text]  
• Hiltunen, L. A., Keinanen-Kiukaanniemi, S. M. (2000). Effects of the WHO 1985 criteria and the proposed new diagnostic criteria on the prevalence of diabetes in an elderly population. Scand J Public Health 28: 266-269 [Abstract]  
• Kilpatrick, E. S (2000). Glycated haemoglobin in the year 2000. J. Clin. Pathol. 53: 335-339 [Full text]  
• DeFronzo, R. A. (1999). Pharmacologic Therapy for Type 2 Diabetes Mellitus. ANN INTERN MED 131: 281-303 [Abstract] [Full text]  
• Turner, R. C., Cull, C. A., Frighi, V., Holman, R. R., for the UK Prospective Diabetes Study Group, (1999). Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes Mellitus: Progressive Requirement for Multiple Therapies (UKPDS 49). JAMA 281: 2005-2012 [Abstract] [Full text]  
• Davidson, M. B., Schriger, D. L., Peters, A. L., Lorber, B. (1999). Relationship Between Fasting Plasma Glucose and Glycosylated Hemoglobin: Potential for False-Positive Diagnoses of Type 2 Diabetes Using New Diagnostic Criteria. JAMA 281: 1203-1210 [Abstract] [Full text]  
• Levy, J., Morris, R., Hammersley, M., Turner, R. (1999). Discrimination, adjusted correlation, and equivalence of imprecise tests: application to glucose tolerance. Am. J. Physiol. Endocrinol. Metab. 276: E365-E375 [Abstract] [Full text]  
• Wareham, N. J, O'Rahilly, S. (1998). The changing classification and diagnosis of diabetes. BMJ 317: 359-360 [Full text]  
• Büettner, R., Schäffler, A., Arndt, H., Rogler, G., Nusser, J., Zietz, B., Enger, I., Hügl, S., Cuk, A., Schölmerich, J., Palitzsch, K.-D. (1998). The Trp64Arg Polymorphism of the {beta} 3-Adrenergic Receptor Gene Is Not Associated with Obesity or Type 2 Diabetes Mellitus in a Large Population-Based Caucasian Cohort. J. Clin. Endocrinol. Metab. 83: 2892-2897 [Abstract] [Full text]  
• Dean, H. (1998). Diagnostic Criteria for Non-Insulin Dependent Diabetes in Youth (NIDDM-Y). CLIN PEDIATR 37: 67-71 [Abstract]  
• Greenhalgh, T. (1997). How to read a paper: Papers that report diagnostic or screening tests. BMJ 315: 540-543 [Full text]  
• Peters, A. L., Davidson, M. B., Schriger, D. L., Hasselblad, V. (1996). A Clinical Approach for the Diagnosis of Diabetes Mellitus: An Analysis Using Glycosylated Hemoglobin Levels. JAMA 276: 1246-1252 [Abstract]  
• Harris, M. I., Eastman, R. C. (1996). Early Detection of Undiagnosed Non--Insulin-Dependent Diabetes Mellitus. JAMA 276: 1261-1262 [Abstract]  
• Simon, K, Sinclair, A, McHugh, D, Roubicek, M, Sanguineti, A G., Vines, G, Jermendy, G, McCance, D R, Hanson, R L, Charles, M A, Jacobsson, L T H, Pettitt, D J, Bennett, P H, Knowler, W C (1994). Tests for diagnosing diabetes mellitus Glucose tolerance test is most sensitive. BMJ 309: 537-538 [Full text]  
• (1994). DIABETES TESTS COMPARED. JWatch General 1994: 4-4 [Full text]